Real‐world data prognostic model of overall survival in patients with advanced NSCLC receiving anti‐PD‐1/PD‐L1 immune checkpoint inhibitors as second‐line monotherapy

Abstract Background and aim The objective of this retrospective, observational, noninterventional cohort study was to investigate prognostic factors of overall survival (OS) in patients with advanced non‐small cell lung cancer (aNSCLC) and to develop a novel prognostic model. Methods A total of 4049...

Descrición completa

Detalles Bibliográficos

Principais autores:	Cristina Julian, Robson J. M. Machado, Sandhya Girish, Pascal Chanu, Dominik Heinzmann, Chris Harbron, Anda Gershon, Shannon M. Pfeiffer, Wei Zou, Valerie Quarmby, Qing Zhang, Yachi Chen
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2022-10-01
Series:	Cancer Reports
Assuntos:	advanced NSCLC immune checkpoint inhibitors prognostic model real‐world data
Acceso en liña:	https://doi.org/10.1002/cnr2.1578
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!